https://doi.org/10.31288/oftalmolzh2017138

Influence of the morphology metrics of serous PED in AMD on the success of triamcinolone acetonide monotherapy
T.B. Kustryn, MD
Filatov Institute of Eye Diseases and Tissue Therapy, NAMS of Ukraine
Odessa, Ukraine
E-mail: laserfilatov@gmail.com
Background: Serous detachment of retinal pigment epithelium (RPE) is a special form of age-related macular degeneration (AMD) and accounts for approximately 10% of all cases of exudative AMD. In the natural course of retinal pigment epithelial detachment (PED), RPE tear, subretinal neovascularization and RPE atrophy develop and are accompanied by severe and irreversible loss of central vision.
Purpose: To determine the prognostic factors for success of triamcinolone acetonide (TA) for serous PED in AMD.
Materials and Methods: Fifty-two patients (54 eyes) with serous PED associated with AMD who were treated with either intravitreal or subtenon TA were followed up over 36 months. At baseline and follow-up visits, they underwent general eye examination including visual acuity assessment, ophthalmoscopy, color fundus photography, long-wave fundusgraphy, fluorescein angiography and macular optical coherence tomography (OCT).
Results: On the basis of a K-means cluster analysis we distinguished two categories of patients with serous PED, which differed in the values of two baseline indices (PED height and length). Over the follow-up period, complete re-attachment was achieved in 60% of cases having higher baseline PED height and more extensive (i.e., longer) baseline PED length versus 23.5% of cases having lower baseline PED height and less extensive baseline PED length (p = 0.01). Triamcinolone acetonide reduced significantly the height and length of PED in both categories of patients over 36 months, with their visual acuity remaining stable compared to the baseline values. Over the 36-month follow-up period, subretinal neovascular membrane developed in 7 (13%) eyes treated with TA.
Conclusion: Higher and more extensive PEDs were found to predict a more favorable response to TA monotherapy. Following administration of TA, complete re-attachment was achieved in 60% of cases having higher baseline PED height and more extensive baseline PED length. Anatomical and morphological features of a serous PED have no effect on the frequency of subretinal neovascular membrane formation.
Key words: serous retinal pigment epithelium detachment, age-related macular degeneration, triamcinolone acetonide

References
1.    Pasyechnikova NV, Korol AR. [Clinical classification and tactics of management of patients with age related macular degeneration]. Oftalmol Zh. 2010;2:38-41 Russian
2.    Bird AC. Doyne Lecture. Pathogenesis of retinal pigment epithelial detachment in the elderly; the relevance of Bruch's membrane change. Eye. 1991;5:1–12
       Crossref   Pubmed
3.    Holz FG, Pauleikhoff D, Klein R, et al. Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol. 2004 Mar;137(3):504-10
       Crossref   Pubmed
4.    Anderson DH, Mullins RF, Hageman GS, et al. A role for local inflammation in the formation of drusen in the aging. Am J Ophthalmol. 2002; 134:411-31
       Crossref   Pubmed
5.    Hageman GS, Luthert PJ, Victor Chong NH, et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001 Nov;20(6):705-32
       Crossref   Pubmed
6.    Dastgheib K, Green WR. Granulomatous reaction to Bruch’s membrane in age-related macular degeneration. Arch Ophthalmol. 1994; 112:813-8
       Crossref   Pubmed
7.    Seregard S, Algvere P, Berglin L. Immunohistochemical characterization of surgically removed subfoveal fibrovascular membranes. Graefes Arch Clin Exp Ophthalmol. 1994 Jun;232(6):325-9
        Crossref   Pubmed
8.    Kustryn TB, Nasinnyk IO, Nevskaya AA, et al. [Changes in structural and functional retinal features resulting from the effect of a long-acting steroid in serous PED associated with AMD: a 36-month follow-up study]. Oftalmol Zh. 2016;5:28-34 Russian
        Crossref
9.    Leitritz M, Gelisken F, Inhoffen W, et al. Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study. Eye. 2008; 22:1504–7
        Crossref   Pubmed
10.    Chan CK, Abraham P, Meyer CH, Kokame GT, et al. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections. Retina. 2010 Feb;30(2):203–11
        Crossref   Pubmed
11.    Doguizi S, Ozdek S. Pigment epithelial tears associated with anti-VEGF therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related macular degeneration. Retina. 2014 Jun;34(6):1156-62
        Crossref   Pubmed
12.    Sarraf D, Chan C, Rahimy E, Abraham P. Prospective evaluation of the incidence and risk factors for the development of RPE tears after high- and low-dose ranibizumab therapy. Retina. 2013 Sep;33(8):1551-7
        Crossref   Pubmed 
13.    Moorfields macular study group. Retinal pigment epithelial detachments in the elderly: a controlled trial of argon laser photocoagulation. Br J Ophthalmology. 1982 Jan; 66(1): 1–16
        Crossref   Pubmed
14.    Barondes MJ, Pagliarinit S, Chisholm IH, et al. Controlled trial of laser photocoagulation of pigment epithelial detachments in the elderly: 4 year review. Br J Ophthalmol. 1992;76(1):5-7
        Crossref   Pubmed